AddLife AB Class B ( (ADDLF) ) has released its Q1 earnings. Here is a breakdown of the information AddLife AB Class B presented to its investors.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
AddLife AB, a prominent player in the Life Science industry, provides high-quality products, services, and advice to both private and public sectors across Europe. The company, which operates through approximately 85 subsidiaries, is listed on Nasdaq Stockholm and boasts over SEK 10 billion in net sales.
In the first quarter of 2025, AddLife AB reported a 5% increase in net sales, reaching SEK 2,702 million. The company also achieved a significant improvement in its EBITA margin, which rose to 12.7% from 11.3% in the previous year. Additionally, AddLife successfully reduced its net debt to EBITDA ratio below 3.0, aligning with its strategic goals.
Key financial metrics for the quarter include an 18% increase in EBITA to SEK 343 million and a 90% rise in profit after tax to SEK 120 million. The company also reported a strong cash flow from operating activities amounting to SEK 240 million. Notably, AddLife completed the acquisition of Edge Medical Ltd., enhancing its presence in the UK market.
Looking ahead, AddLife is poised to continue its strategic focus on margin improvement, organic growth, and increased acquisition activity. The company’s stable market position and ongoing efforts to optimize its product portfolio are expected to support its growth trajectory in the coming quarters.